Covered recipient · General Payments record
MOLLY FURMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2025
$2,095.03
- Reported across 110 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.60 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $59.60 | 4 |
| Otsuka America Pharmaceutical, Inc. | $46.73 | 2 |
| Lilly USA, LLC | $38.39 | 2 |
| Axsome Therapeutics, Inc. | $37.20 | 2 |
| Novo Nordisk AS | $36.46 | 2 |
| Amgen Inc. | $20.04 | 1 |
| DEXCOM, INC. | $19.55 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.06 | 1 |
| GlaxoSmithKline, LLC. | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.80 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201888990 | CMS |
| ABBVIE INC. | $14.89 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201888992 | CMS |
| ABBVIE INC. | $15.25 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201888994 | CMS |
| ABBVIE INC. | $15.66 | 10/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201888996 | CMS |
| Amgen Inc. | $20.04 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228439956 | CMS |
| Axsome Therapeutics, Inc. | $16.56 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235369313 | CMS |
| Axsome Therapeutics, Inc. | $20.64 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235725655 | CMS |
| Dexcom, Inc. | $19.55 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250510126 | CMS |
| GlaxoSmithKline, LLC. | $15.57 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190618315 | CMS |
| Lilly USA, LLC | $21.29 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186805543 | CMS |
| Lilly USA, LLC | $17.10 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186832182 | CMS |
| Novo Nordisk Inc | $18.61 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188951707 | CMS |
| Novo Nordisk Inc | $17.85 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188857959 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.89 | 01/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227329613 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.84 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227329615 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.06 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247280629 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.